Patrick J. Balthrop - 30 Nov 2022 Form 4 Insider Report for MAXCYTE, INC. (MXCT)

Role
Director
Signature
/s/ Brian F. Leaf, attorney-in-fact
Issuer symbol
MXCT
Transactions as of
30 Nov 2022
Transactions value $
$0
Form type
4
Filing time
01 Dec 2022, 15:43:29
Next filing
23 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MXCT Stock Option (right to buy) Award $0 +100K $0.00 100K 30 Nov 2022 Common Stock 100K $5.99 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This annual option grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. 1/3rd of the shares underlying this option vest on November 30, 2023 and the remaining 2/3rds vest in 24 equal monthly installments thereafter, subject to the reporting person's continuous service with the Issuer as of each such vesting date.